[Functional involvement of endogenous anxiogenic neuropeptide in brains]
- PMID: 15291240
[Functional involvement of endogenous anxiogenic neuropeptide in brains]
Abstract
Neuronal GABA(A)/benzodiazepine and monoamine receptors participate in anxiety. Diazepam binding inhibitor (DBI), an endogenous anxiogenic neuropeptide, significantly increases in brains only after treatment with psychological stress, and this increase is completely abolished by benzodiazepines. Therefore, it is through that DBI may be involved in anxiogenesis produced by psychological stress. Furthermore, increases in cerebral DBI are observed in patients with several disorders accompanying anxiety and fear, which suggest that cerebral DBI may be an essential factor for anxiogenesis, and that it may be, at least in part, a biological index to evalulate anxiety.
Similar articles
-
[Functional involvement of diazepam binding inhibitor (DBI) in the establishment of drug dependence].Nihon Arukoru Yakubutsu Igakkai Zasshi. 1998 Apr;33(2):87-99. Nihon Arukoru Yakubutsu Igakkai Zasshi. 1998. PMID: 9613098 Review. Japanese.
-
Chronic administration of methamphetamine increases the mRNA expression of diazepam binding inhibitor in rat brain.Tokai J Exp Clin Med. 2008 Apr 20;33(1):46-50. Tokai J Exp Clin Med. 2008. PMID: 21318965
-
Psychological stress, but not physical stress, causes increase in diazepam binding inhibitor (DBI) mRNA expression in mouse brains.Brain Res Mol Brain Res. 2002 Jul 15;104(1):103-9. doi: 10.1016/s0169-328x(02)00219-x. Brain Res Mol Brain Res. 2002. PMID: 12117556
-
Increase of diazepam binding inhibitor mRNA levels in the brains of chronically ethanol-treated and -withdrawn mice.J Pharmacol Exp Ther. 1995 Jun;273(3):1529-33. J Pharmacol Exp Ther. 1995. PMID: 7791128
-
Pharmacological basis for management of drug dependence.Ann N Y Acad Sci. 2004 Oct;1025:578-83. doi: 10.1196/annals.1316.071. Ann N Y Acad Sci. 2004. PMID: 15542765 Review.